Stock Market News2 weeks CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study Zacks
Cardiff Oncology stock rallies as initial data from a phase II study of onvansertib shows superior efficacy over SOC chemotherapy in colorectal cancer patients.
X2 weeks Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone + Seeking Alpha
X2 weeks Cardiff Oncology price target raised to $10 from $7 at Piper Sandler Yahoo Finance
X2 weeks Cardiff Oncology: The Long-Awaited First-Line MCRC Data Are Here, But The Work Is Just Beginning Seeking Alpha
X2 weeks Cardiff Oncology: Beats Standard Of Care In First Line Metastatic Colorectal Cancer Seeking Alpha
X2 months Short Interest in Cardiff Oncology, Inc. (NASDAQ:CRDF) Expands By 7.2% MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.